Connable Office Inc’s Amgen AMGN Stock Holding History

Connable Office Inc’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.05M	Buy	5,653 +21	+0.4%	+$7.19K	0.18%	75
2026 Q1	$1.98M	Sell	5,632 -131	-2%	-$46.7K	0.2%	70
2025 Q4	$1.89M	Sell	5,763 -3	-0.1%	-$952	0.17%	69
2025 Q3	$1.63M	Sell	5,766 -40	-0.7%	-$11.6K	0.15%	79
2025 Q2	$1.62M	Buy	5,806 +149	+3%	+$42.2K	0.16%	77
2025 Q1	$1.76M	Sell	5,657 -27	-0.5%	-$7.97K	0.19%	71
2024 Q4	$1.48M	Sell	5,684 -1,288	-18%	-$382K	0.15%	79
2024 Q3	$2.25M	Buy	6,972 +37	+0.5%	+$12.1K	0.23%	65
2024 Q2	$2.17M	Sell	6,935 -1,679	-19%	-$493K	0.23%	64
2024 Q1	$2.45M	Sell	8,614 -1,821	-17%	-$533K	0.28%	66
2023 Q4	$3.01M	Sell	10,435 -49	-0.5%	-$13.4K	0.36%	49
2023 Q3	$2.82M	Sell	10,484 -2,217	-17%	-$553K	0.39%	45
2023 Q2	$2.82M	Sell	12,701 -237	-2%	-$55K	0.39%	52
2023 Q1	$3.13M	Sell	12,938 -124	-0.9%	-$30.4K	0.45%	40
2022 Q4	$3.43M	Hold	13,062	–	–	0.49%	35
2022 Q3	$2.94M	Sell	13,062 -59	-0.4%	-$14.3K	0.48%	39
2022 Q2	$3.19M	Buy	13,121 +2,026	+18%	+$496K	0.49%	35
2022 Q1	$2.68M	Sell	11,095 -10	-0.1%	-$2.3K	0.36%	54
2021 Q4	$2.5M	Sell	11,105 -218	-2%	-$46K	0.32%	68
2021 Q3	$2.41M	Sell	11,323 -912	-7%	-$210K	0.35%	63
2021 Q2	$2.98M	Sell	12,235 -17	-0.1%	-$4.18K	0.41%	53
2021 Q1	$3.05M	Sell	12,252 -307	-2%	-$73.3K	0.44%	46
2020 Q4	$2.89M	Hold	12,559	–	–	0.44%	42
2020 Q3	$3.19M	Buy	12,559 +393	+3%	+$97.4K	0.6%	27
2020 Q2	$2.87M	Sell	12,166 -2,643	-18%	-$603K	0.56%	32
2020 Q1	$3M	Sell	14,809 -10	-0.1%	-$2.18K	0.72%	23
2019 Q4	$3.57M	Sell	14,819 -88	-0.6%	-$19.4K	0.61%	28
2019 Q3	$2.88M	Sell	14,907 -59	-0.4%	-$11.3K	0.52%	38
2019 Q2	$2.76M	Sell	14,966 -54	-0.4%	-$9.67K	0.51%	37
2019 Q1	$2.85M	Buy	15,020 +42	+0.3%	+$8.02K	0.55%	38
2018 Q4	$2.92M	Sell	14,978 -446	-3%	-$87K	0.64%	27
2018 Q3	$3.2M	Buy	15,424 +993	+7%	+$196K	0.61%	36
2018 Q2	$2.66M	Buy	14,431 +11	+0.1%	+$1.95K	0.54%	46
2018 Q1	$2.46M	Buy	14,420 +878	+6%	+$161K	0.48%	52
2017 Q4	$2.35M	Sell	13,542 -732	-5%	-$130K	0.46%	53
2017 Q3	$2.66M	Sell	14,274 -500	-3%	-$88.6K	0.54%	44
2017 Q2	$2.54M	Sell	14,774 -333	-2%	-$54.2K	0.56%	44
2017 Q1	$2.48M	Buy	15,107 +2,245	+17%	+$373K	0.56%	48
2016 Q4	$1.88M	Sell	12,862 -181	-1%	-$27.2K	0.43%	58
2016 Q3	$2.18M	Sell	13,043 -167	-1%	-$28.2K	0.52%	49
2016 Q2	$2.01M	Sell	13,210 -228	-2%	-$35.4K	0.56%	49
2016 Q1	$2.02M	Hold	13,438	–	–	0.56%	53
2015 Q4	$2.18M	Sell	13,438 -21	-0.2%	-$3.3K	0.63%	51
2015 Q3	$1.86M	Sell	13,459 -1,881	-12%	-$296K	0.55%	53
2015 Q2	$2.35M	Sell	15,340 -204	-1%	-$32.7K	0.63%	49
2015 Q1	$2.48M	Sell	15,544 -17	-0.1%	-$2.68K	0.64%	46
2014 Q4	$2.48M	Sell	15,561 -9,065	-37%	-$1.41M	0.67%	48
2014 Q3	$3.46M	Hold	24,626	–	–	0.91%	20
2014 Q2	$2.92M	Sell	24,626 -276	-1%	-$31.9K	0.75%	35
2014 Q1	$3.07M	Sell	24,902 -272	-1%	-$33K	0.84%	33
2013 Q4	$2.87M	Sell	25,174 -201	-0.8%	-$22.9K	0.78%	36
2013 Q3	$2.84M	Sell	25,375 -29	-0.1%	-$3.15K	0.8%	32
2013 Q2	$2.51M	Buy	+25,404	New	+$2.64M	0.71%	40

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Connable Office Inc's AMGN Position: Q2 2026 in Review

Connable Office Inc increased its Amgen (AMGN) stake by 0.37% in Q2 2026, buying an estimated $7.19K and bringing the position to 5,653 shares worth $2.05M. The position accounts for 0.18% of the portfolio, ranked #75.

Connable Office Inc first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.57M in Q4 2019. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Connable Office Inc held 5,653 shares of Amgen worth $2.05M as of Q2 2026.
Connable Office Inc bought 21 Amgen shares in Q2 2026, an estimated $7.19K.
Amgen made up 0.18% of Connable Office Inc's portfolio in Q2 2026, its #75 holding.
Connable Office Inc first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
Connable Office Inc's Amgen position peaked at $3.57M in Q4 2019.
3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Connable Office Inc's 13F filing for Q2 2026, filed 3 Aug 2026.